Seven countries in sub-Saharan Africa, the world's worst-hit region in the global AIDS epidemic, have cut the number of new HIV infections in children by 50 percent since 2009, the United Nations AIDS program said on Tuesday.
U.S. groups that work to end HIV around the world will no longer be forced to take a pledge against prostitution, after the Supreme Court ruled last week it is a violation of free speech.
This month somewhere in sub-Saharan Africa the 1 millionth baby will be born without HIV to a mother who suffers from the disease, thanks in large part to a decade-old U.S. aid program.
Doctors should consider giving a daily AIDS drug to another high risk group to help prevent infections — people who shoot heroin, methamphetamines or other injection drugs, U.S. health officials said Wednesday.
AIDS claimed seven lives among young people aged 15-24 in Taiwan in 2012, making it the country's No. 10 cause of death in this age bracket, the Department of Health (DOH) said yesterday.
2013/6/7, 1 Comment
The hunt for an HIV vaccine has gobbled up US$8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
In another major setback for efforts to develop a vaccine to boost immunity to the human immunodeficiency virus, known as HIV, a key clinical trial was ordered shut down this week after an independent panel of safety experts found that participants getting the vaccine appeared to be slightly more likely to contract the virus and no better at suppressing its replication than those who got a placebo.
South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day.
Scientists on a quest for an antibody-based AIDS vaccine said Wednesday they found promising clues in the uncommonly “robust” natural immune response of a patient in Africa.